The purpose of this FOA in Guyana is to provide technical assistance and funding to local indigenous organizations to improve access to quality Antiretroviral therapy (ART) clinical services. Activities will focus on delivering tailored services for key populations, improving linkage to care, retention on ART and will ensure sustainable service delivery within faith based-affiliated sites in Guyana.
This Funding Opportunity Announcement (FOA) encourages Exploratory and developmental bi-phasic research applications to support the identification and optimization of small molecules or RNAs that interact with host epigenetic machinery to mediate long-term or permanent epigenetic silencing of HIV-1 proviruses.
The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to use innovative technology to conduct epidemiologic studies of large cohorts of U.S. populations at high risk of HIV infection: men who have sex with men (MSM), transgender women, and black/African American women. The UG3/UH3 Phased Innovation Awards Cooperative Agreement involves 2 phases. Funding for a UG3 phase will be used to enroll and follow sufficient numbers of high-risk HIV-negative participants to reach seroconversion milestone targets.
This Funding Opportunity Announcement (FOA) encourages innovative, high risk, high impact research to investigate the innate and/or adaptive immune responses induced by mycobacterial infections, Bacillus Calmette-Guérin vaccine (BCG) and/or candidate Mycobacterium tuberculosis (Mtb) vaccines in HIV-infected or uninfected individuals. Studies that will provide insights into the immune mechanisms required for protection from Mtb infection/re-infection or progression to active disease in latently infected individuals are encouraged.
This announcement solicits applications for the fiscal year (FY) 2016 Leadership Training for People of Color Living with HIV program. This program supports the development and delivery of training programs for people of color living with HIV of all ages (e.g., Black, Hispanic/Latino, American Indian/Alaskan Native (AI/AN), and Asian/Pacific Islander (API)) to enable full, active and engaged participation on planning bodies, medical and support care teams, boards of directors, and other mobilization efforts to address the goals of the National HIV/AIDS Strategy: Updated to 2020 (NHAS 2020).
The purpose of this Funding Opportunity Announcement (FOA) is to support multi-disciplinary, Program Project applications aimed at understanding specific mechanisms, biomarkers, and pathways associated with rebound of HIV viremia.
NIMH calls for FY16 administrative supplements that would conduct implementation science research related to a Centers for Disease Control and Prevention (CDC)-funded public health initiative to reduce HIV infections in men who have sex with men (MSM) and transgender individuals through improved HIV pre-exposure prophylaxis (PrEP) planning, outreach, and delivery. Applicants are required to establish collaborative partnerships with Public Health Departments conducting PrEP demonstration projects funded through CDC Funding Opportunity Announcement CDC-RFA-PS15-1506 (CDC Project PrIDE).
This funding opportunity announcement invites research grant applications focused on: identifying HIV-1-infected cells in the central nervous system (CNS) compartment that are latently infected; developing strategies for targeting these latently infected cells; and aiming to achieve viral silencing leading to inhibition of viral production, without the need for pro-viral reactivation.
The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT), announces the availability of one-year supplemental funding to enable grantees from the Targeted Capacity Expansion: Substance Abuse Treatment for Racial/Ethnic Minority Women at High Risk for HIV/AIDS Minority Women (TCE-HIV: Minority Women) cohort funded in FY 2014 to expand/enhance grant activities required under the Request for Application (RFA), TI-13-011.
The purpose of this Funding Opportunity Announcement (FOA) is to promote multidisciplinary research programs that (1) devise optimal HIV prevention packages (combination interventions) for specific populations and (2) perform feasibility and acceptability studies to demonstrate that the proposed prevention package is acceptable to the target population and the study design is appropriate and feasible. This FOA is intended to encourage collaborations between behavioral and biomedical clinical specialists, epidemiologists, mathematical modelers, and clinical research specialists.